Personalis Inc. Common Stock vs Phillips 66 — how do they compare? Personalis Inc. Common Stock trades at $16.07 (market cap $1.69B), while Phillips 66 trades at $297 (market cap $116.81B). The key difference: Phillips 66 is far larger — about 69.1× Personalis Inc. Common Stock's market cap, and Phillips 66 pays a 1.74% dividend while Personalis Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Personalis Inc. Common Stock for 0 Days and Phillips 66 for 63 Days on average.
| PSNL | PSX | |
|---|---|---|
Market Cap | $1.69B | $116.81B |
Volume | 3,817,236 | 2,609,145 |
Sector | Health | Energy |
52-Week High | $18.38 | $297.29 |
52-Week Low | $5.04 | $127.75 |
Typical Hold Time | 0 Days | 63 Days |
Enterprise Value | $1.52B | $133.27B |
Dividend Yield | — | 1.74% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Phillips 66 (PSX) trades at $297.29, up 5.62% on the day, showing strong momentum near recent highs. The stock demonstrates solid fundamentals with a P/E of 16.71 and P/S of 0.78, while recent earnings beats and a 24.02% ROE highlight operational strength. Technical indicators show bullish momentum with the current price above key support levels. Recent news highlights structural advantages in refining margins and AI implementation for operational efficiency.
PSX presents a compelling investment case with strong profitability metrics and positive analyst sentiment (54% buy ratings), though current price exceeds the $286.90 consensus target. Key risks include refining margin volatility and potential policy impacts on diesel exports. The company's debt reduction progress and projected 2026 net cash flow of $3.0B support the bullish outlook despite competitive pressures.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Personalis Inc. is a cancer genomics company that provides tumor- and blood-based DNA and RNA sequencing tests, including its NeXT Personal liquid biopsy test for cancer monitoring.
Read more on PSNL →Phillips 66 is an independent refiner with 12 refineries that have a total crude throughput capacity of 2.0 million barrels per day, or mmb/d, after converting its 255 mb/d Alliance refinery to a terminal. The midstream segment comprises extensive transportation and NGL processing assets. It also includes its DCP Midstream joint venture, which holds 45 natural gas processing facilities, 11 NGL fractionation plants, and a natural gas pipeline system with 58,000 miles of pipeline. Its CPChem chemical joint venture operates facilities in the United States and the Middle East and primarily produces olefins and polyolefins.
Read more on PSX →